TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25514451

Group type: COMPARATOR
Intervention: Extended Bandwidth (EBW) hearing aid processing
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Nonlinear Frequency Compression (NFC) hearing aid processing
Number of subjects: 32

Group type: COMPARATOR
Intervention: Restricted Bandwidth (RBW) hearing aid processing
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Music processing
Number of subjects: 32
Study: 20676755

Group type: EXPERIMENTAL
Intervention: Recent aspirin use
Number of subjects: 2987

Group type: EXPERIMENTAL
Intervention: SNP rs2745559
Number of subjects: 2987

Group type: EXPERIMENTAL
Intervention: Other SNPs
Number of subjects: 2987
Study: 20629476

Group type: EXPERIMENTAL
Intervention: Factor V Leiden (FVL) testing
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Prothrombin G20210A testing
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Anticoagulation treatment
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Testing for FVL and prothrombin G20210A
Number of subjects: 124
Study: 17462588

Group type: EXPERIMENTAL
Intervention: Cognitive therapy methods focusing on childhood memories
Number of subjects: 21

Group type: COMPARATOR
Intervention: Cognitive therapy methods focusing on the present
Number of subjects: 21

Group type: COMPARATOR
Intervention: Order of focus (past-present vs present-past)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Experience of the therapist with CT for personality disorders
Number of subjects: 21
Study: 15109992

Group type: EXPERIMENTAL
Intervention: Working memory tasks in Chinese (L1)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Working memory tasks in English (L2)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Functional MRI imaging during working memory tasks
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Volume of activation in left opercularis region, left parietal lobule, and right precentral region
Number of subjects: 12
Study: 11338045

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (NC)
Number of subjects: 76

Group type: COMPARATOR
Intervention: No neoadjuvant chemotherapy (Control)
Number of subjects: 76
Study: 10423597

Group type: EXPERIMENTAL
Intervention: Lovastatin (20 mg/d)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Gemfibrozil (600 mg twice a day)
Number of subjects: 18
Study: 7515382

Group type: EXPERIMENTAL
Intervention: Xylometazoline 0.1% vasoconstrictor nasal spray
Number of subjects: 80

Group type: COMPARATOR
Intervention: Plain Magill red rubber endotracheal tube
Number of subjects: 80
Study: 3665737

Group type: EXPERIMENTAL
Intervention: Piretanide
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acebutolol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine and Acebutolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: All three drugs
Number of subjects: 0
Study: 30043749

Group type: EXPERIMENTAL
Intervention: Baricitinib 4 mg
Number of subjects: 314

Group type: EXPERIMENTAL
Intervention: Baricitinib 2 mg
Number of subjects: 314

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 314
Study: 27830836

Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (counseling on diet and exercise every 3 months via phone call)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control (counseling in annual checkups without regular intervention)
Number of subjects: 280
Study: 25518308

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 219

Group type: COMPARATOR
Intervention: Control group (routine antenatal care)
Number of subjects: 219
Study: 22436156

Group type: EXPERIMENTAL
Intervention: Carnitine-supplemented diet
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 16
Study: 20339969

Group type: EXPERIMENTAL
Intervention: Nebivolol (5 mg daily for 4 weeks)
Number of subjects: 38
Study: 17629923

Group type: EXPERIMENTAL
Intervention: Salmeterol/fluticasone propionate (SFC) 50/100 mug twice daily
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluticasone propionate (FP) 100 mug twice daily
Number of subjects: 0
Study: 15668601

Group type: EXPERIMENTAL
Intervention: Soy protein containing 52 mg genistein, 41 mg daidzein, and 6 mg glycitein daily for 1 year
Number of subjects: 202

Group type: COMPARATOR
Intervention: Milk protein (placebo) daily for 1 year
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Soy protein
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 12029552

Group type: EXPERIMENTAL
Intervention: Iodine-131 iodide (120 MBq) as diagnostic agent, followed by ablation activity of 131I iodide (4,000 MBq) administered 3-38 days later.
Number of subjects: 26

Group type: COMPARATOR
Intervention: Iodine-123 iodide (200 MBq) as diagnostic agent, followed by ablation activity administered 5-47 days later.
Number of subjects: 26
Study: 10408210

Group type: EXPERIMENTAL
Intervention: Audiotape
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Videotape
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 7584730

Group type: EXPERIMENTAL
Intervention: Zopiclone 7.5 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 2138186

Group type: EXPERIMENTAL
Intervention: Colchicine, 0.5 mg twice daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 394315

Group type: EXPERIMENTAL
Intervention: Intracavitary streptokinase/streptodornase
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oral streptokinase/streptodornase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 30706792

Group type: EXPERIMENTAL
Intervention: Walking exercise program, 24 weeks, five times per week
Number of subjects: 100

Group type: COMPARATOR
Intervention: Routine activities (Control group)
Number of subjects: 100
Study: 28816195

Group type: EXPERIMENTAL
Intervention: Active tieback
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: NiTi coil spring
Number of subjects: 25
Study: 26014294

Group type: EXPERIMENTAL
Intervention: Bevacizumab (B) 15 mg/kg intravenously plus Carboplatin (CP) and Paclitaxel (CP)
Number of subjects: 276

Group type: COMPARATOR
Intervention: Placebo (Pl) plus Carboplatin (CP) and Paclitaxel (CP)
Number of subjects: 276
Study: 23907665

Group type: EXPERIMENTAL
Intervention: GSK1322322 (oral or intravenous administration)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Single oral doses of GSK1322322 (1,000 and 1,500 mg)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Repeat IV doses of GSK1322322 (500 to 1,500 mg twice daily)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Supratherapeutic single IV doses of GSK1322322 (2,000 and 3,000 mg)
Number of subjects: 62
Study: 20717049

Group type: EXPERIMENTAL
Intervention: Bevacizumab (1.25 mg in 0.05 mL) injected around the valve body after surgery
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Mitomycin C (0.4 mg/mL for 3 min) applied before valve implantation
Number of subjects: 20

Group type: COMPARATOR
Intervention: Ahmed valve only (control group)
Number of subjects: 20
Study: 19013598

Group type: EXPERIMENTAL
Intervention: Sildenafil (50 to 100 mg)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 203
Study: 16420138

Group type: EXPERIMENTAL
Intervention: Enhanced counseling and support intervention
Number of subjects: 406

Group type: COMPARATOR
Intervention: Usual care control condition
Number of subjects: 406
Study: 12463600

Group type: EXPERIMENTAL
Intervention: Allogeneic HSCT from related donors other than genotypically HLA‐matched siblings
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (HSCT from genotypically HLA‐matched siblings)
Number of subjects: 30
Study: 10354813

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture at the Lung Point
Number of subjects: 23

Group type: COMPARATOR
Intervention: Control group (no acupuncture)
Number of subjects: 23
Study: 7593877

Group type: EXPERIMENTAL
Intervention: Parent training and marital problem solving intervention for 10 months
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Maternal treatment investment
Number of subjects: 42
Study: 2199847

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (Botox) injections
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Botulinum toxin (Botox) injections (higher dose during open phase)
Number of subjects: 55
Study: 6171899

Group type: EXPERIMENTAL
Intervention: Cimetidine (52 patients)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control (64 patients)
Number of subjects: 116
Study: 30568009

Group type: EXPERIMENTAL
Intervention: Honda Stride Management Assist (SMA) exoskeleton
Number of subjects: 50

Group type: COMPARATOR
Intervention: Functional gait training
Number of subjects: 50
Study: 28898378

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE, 0.625 mg/d) plus medroxyprogesterone acetate (MPA, 2.5 mg/d) (n=8506)
Number of subjects: 27347

Group type: EXPERIMENTAL
Intervention: Conjugated equine estrogens (CEE, 0.625 mg/d) alone (n=5310)
Number of subjects: 27347

Group type: COMPARATOR
Intervention: Placebo (n=8102 for CEE+MPA, n=5429 for CEE alone)
Number of subjects: 27347

Group type: EXPERIMENTAL
Intervention: Hormone therapy (CEE+MPA or CEE)
Number of subjects: 27347
Study: 25752195

Group type: EXPERIMENTAL
Intervention: 4-hexyl-1,3-phenylenediol
Number of subjects: 59

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 59
Study: 24212847

Group type: EXPERIMENTAL
Intervention: Transconjunctival needling revision with 5-fluorouracil
Number of subjects: 40

Group type: COMPARATOR
Intervention: Medical treatment (hypotensive eyedrops)
Number of subjects: 40
Study: 22013796

Group type: EXPERIMENTAL
Intervention: Wangbi Tablet (WT)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: WT + Votalin Tablet
Number of subjects: 160

Group type: COMPARATOR
Intervention: Votalin Tablet
Number of subjects: 160
Study: 20001655

Group type: EXPERIMENTAL
Intervention: Losartan-based therapy
Number of subjects: 9193

Group type: COMPARATOR
Intervention: Atenolol-based therapy
Number of subjects: 9193
Study: 17284923

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 90
Study: 16230756

Group type: EXPERIMENTAL
Intervention: Direct care providers with 1 to 2 years of experience
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Person-centered attitude
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: Perceived competence in providing dementia care
Number of subjects: 154
Study: 11900820

Group type: EXPERIMENTAL
Intervention: 2 mg of nicotine polacrilex
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 9873242

Group type: EXPERIMENTAL
Intervention: Preventive intervention program (lessons and group discussions on adolescent problems and eating disorders)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Control group (154 subjects)
Number of subjects: 254
Study: 7669459

Group type: EXPERIMENTAL
Intervention: Oral naproxen 1 g
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 2040354

Group type: EXPERIMENTAL
Intervention: Porcine surfactant (Curosurf, 200 mg/kg body weight)
Number of subjects: 164
Study: 7044788

Group type: EXPERIMENTAL
Intervention: 4 mg orgotein (intra-articular injections, 4 weekly)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (intra-articular injections, 4 weekly)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Orgotein
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 31559433

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (3000 IU daily for 26 weeks)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation
Number of subjects: 66
Study: 28052977

Group type: EXPERIMENTAL
Intervention: Diabetes mellitus
Number of subjects: 4128

Group type: COMPARATOR
Intervention: No diabetes mellitus
Number of subjects: 4128
Study: 25037460

Group type: EXPERIMENTAL
Intervention: Emotion Dysregulation (ED)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Non-clinical and subclinical levels of depression
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Clinical levels of depression
Number of subjects: 171
Study: 25607562

Group type: EXPERIMENTAL
Intervention: Long-pulsed Nd:YAG 1064 nm laser intervention for fingernails (Group 1)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Long-pulsed Nd:YAG 1064 nm laser intervention for toenails (Group 2)
Number of subjects: 37
Study: 21546102

Group type: EXPERIMENTAL
Intervention: 150 mg clopidogrel
Number of subjects: 46

Group type: COMPARATOR
Intervention: 75 mg clopidogrel
Number of subjects: 46
Study: 19443430

Group type: EXPERIMENTAL
Intervention: CFAE ablation
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation, roof line, and mitral isthmus ablation
Number of subjects: 41
Study: 17360152

Group type: EXPERIMENTAL
Intervention: Ekman 60 Faces Test
Number of subjects: 25

Group type: COMPARATOR
Intervention: Cognitively healthy subjects (HC)
Number of subjects: 25
Study: 15498633

Group type: EXPERIMENTAL
Intervention: Blue dye alone (Group A)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combined blue dye and radioactive tracer (Group B)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Comparison of techniques
Number of subjects: 150
Study: 11270920

Group type: EXPERIMENTAL
Intervention: Guanfacine
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Dextroamphetamine
Number of subjects: 17
Study: 9874861

Group type: EXPERIMENTAL
Intervention: Oral clonidine 150 micrograms
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 7979499

Group type: EXPERIMENTAL
Intervention: Cyclosporin
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional treatment (enteral nutrition or corticosteroids)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 24
Study: 2692580

Group type: EXPERIMENTAL
Intervention: Amoxycillin/clavulanate
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study: 29869405

Group type: EXPERIMENTAL
Intervention: L-T4
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: T3
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 26565690

Group type: EXPERIMENTAL
Intervention: High-Intensity Hatha Yoga (HIY) for 6 weeks (60 minutes once a week)
Number of subjects: 44
Study: 23817506

Group type: EXPERIMENTAL
Intervention: Simvastatin 80 mg
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 23166292

Group type: EXPERIMENTAL
Intervention: Study trials associated with accurate location memory
Number of subjects: 0

Group type: COMPARATOR
Intervention: Study trials associated with inaccurate location memory
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Successful encoding of voice information
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Trials for which both contextual features were later retrieved
Number of subjects: 0
Study: 20460239

Group type: EXPERIMENTAL
Intervention: Fortified soymilk (20 mL with 185 kBq of 45Ca in 44 mg of calcium carrier)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cow's milk
Number of subjects: 12
Study: 17570262

Group type: EXPERIMENTAL
Intervention: Medium-chain triglyceride (MCT), 18 g/d for 90 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Corn oil (long-chain triglycerides, LCT)
Number of subjects: 40
Study: 16034259

Group type: EXPERIMENTAL
Intervention: 50 ml syringe training aid
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 64
Study: 12439536

Group type: EXPERIMENTAL
Intervention: Evening primrose oil
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control oil for evening primrose oil
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control oil for fish oil
Number of subjects: 120
Study: 10406151

Group type: EXPERIMENTAL
Intervention: 6-year-olds with uncorrected visual acuity below 0.5
Number of subjects: 6292

Group type: EXPERIMENTAL
Intervention: 12-year-olds with uncorrected visual acuity below 0.5
Number of subjects: 6292

Group type: EXPERIMENTAL
Intervention: 12-year-old girls in Nizwa, Dakhlia
Number of subjects: 6292

Group type: COMPARATOR
Intervention: 12-year-olds in rural, remote areas
Number of subjects: 6292
Study: 8665540

Group type: EXPERIMENTAL
Intervention: Octreotide (100 micrograms s.c.)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 9
Study: 2209029

Group type: EXPERIMENTAL
Intervention: Ibustrin
Number of subjects: 49

Group type: COMPARATOR
Intervention: ASA and dipyridamole
Number of subjects: 49
Study: 6996107

Group type: EXPERIMENTAL
Intervention: Ibuprofen (400 mg)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Propoxyphene hydrochloride (64 mg)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 30106311

Group type: EXPERIMENTAL
Intervention: Emulsified cod liver oil formulation
Number of subjects: 47
Study: 29609568

Group type: EXPERIMENTAL
Intervention: 10-session MAISHA curriculum delivered over 20 weeks
Number of subjects: 66

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: 10-session MAISHA curriculum
Number of subjects: 66
Study: 27236884

Group type: EXPERIMENTAL
Intervention: Acupuncture combined with medicine (ACM) - electro-acupuncture combined with injection of dexmedetomidine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional analgesia - injection of dexmedetomidine
Number of subjects: 50
Study: 24872682

Group type: EXPERIMENTAL
Intervention: SDX (600 lipoprotein lipase‐releasing units/day intramuscularly for 15 days followed by 250 lipase‐releasing units every 12 hours orally for 6 months)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard treatment (compression therapy and surgery)
Number of subjects: 53
Study: 22772512

Group type: EXPERIMENTAL
Intervention: Haloperidol-propofol infusion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Midazolam-propofol infusion
Number of subjects: 60
Study: 20186889

Group type: EXPERIMENTAL
Intervention: TEP (totally extraperitoneal patch)
Number of subjects: 1512

Group type: COMPARATOR
Intervention: Lichtenstein
Number of subjects: 1512

Group type: EXPERIMENTAL
Intervention: TEP
Number of subjects: 1512
Study: 17913000

Group type: EXPERIMENTAL
Intervention: Fluocaril Sensia (FSTB)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Elgydium Interactive (ELTB)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Elmex InterX (ETB)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Butler 211 (BTB)
Number of subjects: 12

Group type: COMPARATOR
Intervention: All toothbrushes
Number of subjects: 12
Study: 16052120

Group type: EXPERIMENTAL
Intervention: 10 U BoNT‐A
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 25 U BoNT‐A
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: 50 U BoNT‐A
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 132
Study: 11978287

Group type: EXPERIMENTAL
Intervention: Isotretinoin at 0.5 mg/kg per day for 6 months
Number of subjects: 117

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 117
Study: 10760294

Group type: EXPERIMENTAL
Intervention: DHEA, 50 mg, orally, daily for a year
Number of subjects: 280

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 280
Study: 8933125

Group type: EXPERIMENTAL
Intervention: Fish diet (4.3 meals per week for 15 weeks)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Fish oil (4 g oil per day for 15 weeks)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: DHA-rich oil (4 g oil per day for 15 weeks)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: All test groups (Fish diet, Fish oil, DHA-rich oil)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Fish diet and Fish oil
Number of subjects: 55
Study: 1434268

Group type: EXPERIMENTAL
Intervention: Oral prostaglandin E1 (limaprost)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 3902525

Group type: EXPERIMENTAL
Intervention: Ambulation
Number of subjects: 57

Group type: COMPARATOR
Intervention: Oxytocin
Number of subjects: 57
Study: 30690085

Group type: EXPERIMENTAL
Intervention: Radiation therapy regimens (41 identified)
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Typical CT scan
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: LADCA segments
Number of subjects: 470

Group type: EXPERIMENTAL
Intervention: Individual regimens
Number of subjects: 470
Study: 29357894

Group type: EXPERIMENTAL
Intervention: Standard Care + Enhanced Program
Number of subjects: 360

Group type: COMPARATOR
Intervention: Standard Care Alone
Number of subjects: 360
Study: 27328311

Group type: EXPERIMENTAL
Intervention: Nutritional intervention (dietary advice)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Nutritional intervention (oral supplementation)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Nutritional intervention (major intervention)
Number of subjects: 258

Group type: COMPARATOR
Intervention: Cetuximab patients receiving major nutritional intervention
Number of subjects: 258
Study: 24738467

Group type: COMPARATOR
Intervention: Shuganyiyang Capsules
Number of subjects: 90

Group type: COMPARATOR
Intervention: Tadalafil
Number of subjects: 90

Group type: COMPARATOR
Intervention: Tadalafil + Shuganyiyang Capsules
Number of subjects: 90
Study: 23763511

Group type: EXPERIMENTAL
Intervention: Gemcitabine plus S-1 (GS)
Number of subjects: 101

Group type: COMPARATOR
Intervention: S-1
Number of subjects: 101
Study: 20804302

Group type: EXPERIMENTAL
Intervention: Directed forgetting (forget group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control remember group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Directed forgetting with item-specific encoding
Number of subjects: 0
Study: 19047702

Group type: EXPERIMENTAL
Intervention: Posterior cruciate ligament-substituting design
Number of subjects: 100

Group type: COMPARATOR
Intervention: Posterior cruciate ligament-retaining design
Number of subjects: 100
Study: 16005623

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol 160/4.5 microg (640/18 microg/day)
Number of subjects: 133

Group type: COMPARATOR
Intervention: Budesonide 320 microg (1280 microg/day)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol
Number of subjects: 133